Create a free QxMD account to take advantage of the features offered by Read like saving your papers and creating collections.

Get Started

JOURNAL ARTICLE

REVIEW

[Endocannabinoid and endocannabinoid receptor antagonists]

Susanne Heinzl

Medizinische Monatsschrift Für Pharmazeuten 2005, 28 (2): 40-3

No abstract text is available yet for this article.

Full Text Links

Find Full Text Links for this Article

You are not logged in. Sign Up or Log In to join the discussion.

Drug development. Drugs inspired by a drug. Jean Marx Science 2006 January 20, 311 (5759): 322-5

Impairments in endocannabinoid signaling and depressive illness. Matthew N Hill, Boris B Gorzalka JAMA 2009 March 18, 301 (11): 1165-6

[Rimonabant (Acomplia), specific inhibitor of the endocannabinoid system]. J Ducobu, J Sternon Journal de Pharmacie de Belgique 2005, 60 (3): 89-91

The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use. S Xie, M A Furjanic, J J Ferrara, N R McAndrew, E L Ardino, A Ngondara, Y Bernstein, K J Thomas, E Kim, J M Walker, S Nagar, S J Ward, R B Raffa Journal of Clinical Pharmacy and Therapeutics 2007, 32 (3): 209-31

Endocannabinoid control of food intake and energy balance. Vincenzo Di Marzo, Isabel Matias Nature Neuroscience 2005, 8 (5): 585-9

Minireview: Endocannabinoids and their receptors as targets for obesity therapy. Annette D de Kloet, Stephen C Woods Endocrinology 2009, 150 (6): 2531-6

[Selective cannabinoid receptor antagonists]. Susanne Kreutz, Horst-Werner Korf, Manfred Schubert-Zsilavecz Pharmazie in Unserer Zeit 2006, 35 (6): 512-20

The endocannabinoid system: potential for reducing cardiometabolic risk. Henry N Ginsberg, Stephen C Woods Obesity 2009, 17 (10): 1821-9

Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity. Carlos E Leite, Clei A Mocelin, Guilherme O Petersen, Mirna B Leal, Flavia V Thiesen Pharmacological Reports: PR 2009, 61 (2): 217-24

Make the most of Read.
Download the mobile app.

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Read